LUNA INNOVATIONS INCORPORATED — Department of Health and Human Services SBIR Phase I: ODCDC

Description

InoverAmericans died as a result of opioid overdosemaking opioid use the leading cause of death for Americans underThis crisis affects both males and femalesthus leading to a surge in the number of babies born with opioid addictionthe withdrawal from which is termed Neonatal Abstinence SyndromeNASIninstances of newborn opioid dependence were recordedDiagnostic metrics seek to standardize diagnosis and treatmentyet differences in assessments lead to treatment variabilityClearlythis field would benefit from a system capable of repeatableaccurateNAS symptom quantificationTo address this needand building upon on significant experience in low power embedded electronics developmentLuna Innovationswww lunainc com lunalabsand its partners at Elder Research propose the development of the Pediatric Opioid Withdrawal Researchor POWR Systema wearable device capable of providing accurate symptom measurements of Neonatal Abstinence Syndrome in the clinical environmentLuna will adapt its existing passive condition monitoring system by integrating accelerometryaudio processingand skin surface electrodes to quantify NAS symptoms of interest including cry characteristicsmuscle tremors and tonesleep patternsand skin temperature